Neoadjuvant Doxorubicin/Cyclophosphamide Followed by Docetaxel (AC-Doc) Versus Dose-Dense Doxorubicin and Docetaxel (ADoc) in Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Primary Breast Cancer
Interventions: DRUG: Adriamycin (Doxorubicin), Docetaxel, Tamoxifen|DRUG: Adriamycin (Doxorubicin), Docetaxel, Tamoxifen, Cyclophosphamid
Sponsor: German Breast Group
Collaborators: German Adjuvant Breast Cancer Group